
John Kawola transitions to strategic advisor as BMF restructures leadership
Post-Processing
Originally reported by TCT Magazine
Boston Micro Fabrication (BMF) announced that CEO John Kawola will step into a strategic advisor role effective July 1, 2026, as part of a broader management restructuring. Bryan Ferrand has been appointed President, and Donna Kelly promoted to Chief Operating Officer. The changes aim to position the company for its next growth phase, with Kawola continuing to support the leadership team and long-term direction. BMF cited growing demand for its micro-precision 3D printing across medical devices, electronics, biotechnology, and other high-value manufacturing sectors.
This leadership transition comes at a critical juncture for BMF, which operates in the vat photopolymerization segment with a focus on ultra-high-resolution printing for applications where micron-level accuracy is non-negotiable. The company has carved a defensible niche in micro-precision AM, competing indirectly with firms like Nanoscribe and UpNano, but with a stronger commercial orientation toward production-grade medical and electronics components. The appointment of Ferrand as President and Kelly as COO signals an emphasis on operational discipline and scaling customer success, rather than pure technology push. For the polymer VPP segment, which often struggles to escape prototyping into production, BMF's ability to execute on this operational pivot will determine whether micro-precision AM becomes a genuine production tool or remains a specialized niche.
Practically, this move reflects a company preparing for institutional scaling rather than a response to crisis. Kawola's retention as advisor preserves continuity, while the new leadership team must now demonstrate that BMF can convert its technical lead in micro-precision into repeatable, cost-effective production workflows for regulated industries. The real test will be whether the company can expand its customer base beyond early adopters and into the qualification-heavy medical device and electronics supply chains, where process repeatability and quality governance matter more than resolution specs alone.
Topics